Percheron Therapeutics continues to advance Duchenne treatment

By Proactive Investors / March 06, 2024 / www.youtube.com / Article Link


Percheron Therapeutics Ltd (ASX:PER) managing director and CEO James Garner sits down with Proactive's Jonathan Jackson ...

Recent News

US tariff decision expected to be major copper catalyst

July 07, 2026 / www.canadianminingreport.com

Gold stocks rebound from near lows

July 07, 2026 / www.canadianminingreport.com

Gold stocks decline as metal price drops

June 29, 2026 / www.canadianminingreport.com

Tech takes a hit on South Korea semiconductor decline

June 29, 2026 / www.canadianminingreport.com

Gold stocks rise even as metal drops for second week

June 22, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok